Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 941

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9
Chunk 941
---
 committee of any entity that has one or more executive officers serving on our compensation
committee.

Risk
Oversight

One
of the key functions of our board of directors is informed oversight of our risk management process. Our board of directors administers
this oversight function directly through our board of directors as a whole, and through various standing committees of our board of directors
that address risks inherent in their respective areas of oversight. In particular, our board of directors is responsible for monitoring
and assessing strategic risk exposure, including risks associated with cybersecurity and data protection, and our audit committee has
the responsibility to consider our major financial risk exposures and the steps our management has taken to monitor and control these
exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. Our audit committee
will review legal, regulatory, and compliance matters that could have a significant impact on our financial statements. Our nominating
and corporate governance committee will monitor the effectiveness of our corporate governance practices, including whether they are successful
in preventing illegal or improper liability-creating conduct. Our compensation committee will assess and monitor whether any of our compensation
policies and programs has the potential to encourage excessive risk taking. While each committee is responsible for evaluating certain
risks and overseeing the management of such risks, our entire board of directors will be regularly informed through committee reports
about such risks.

70

Code
of Business Conduct and Ethics

Our
board of directors has adopted a code of business conduct and ethics applicable to all of our directors, officers (including our principal
executive officer, principal financial officer, and principal accounting officer) and all global employees in accordance with applicable
federal securities laws and corporate governance rules of the Nasdaq Capital Market. Our code of business conduct and ethics is available
on our website. Any amendments to the code of business conduct and ethics, or waivers of its requirements, will, if required, be disclosed
on our website.

Insider
Trading Policy

Our
board of directors has adopted an insider trading policy filed hereto as Exhibit 19.1 and is incorporated herein by this reference.

Corporate
Governance Guidelines

Our
board of directors has adopted corporate governance guidelines, a copy of which is available on our website.

Director
Compensation

We
did not provide any cash compensation to any of our directors during the year ended December 31, 2024 in their capacity as directors.
However, on April 25, 2024, Matthew Del Giudice,